Correction: Leveraging T cell co-stimulation for enhanced therapeutic efficacy of trispecific antibodies targeting prostate cancer
- PMID: 40139838
- PMCID: PMC11950989
- DOI: 10.1136/jitc-2024-010140corr1
Correction: Leveraging T cell co-stimulation for enhanced therapeutic efficacy of trispecific antibodies targeting prostate cancer
Erratum for
-
Leveraging T cell co-stimulation for enhanced therapeutic efficacy of trispecific antibodies targeting prostate cancer.J Immunother Cancer. 2025 Mar 13;13(3):e010140. doi: 10.1136/jitc-2024-010140. J Immunother Cancer. 2025. PMID: 40081942 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources